Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia.

Psychopharmacology

“Nighttime agitation occurs frequently in patients with dementia and represents the number one burden on caregivers today. Current treatment options are few and limited due to substantial side effects.

OBJECTIVES:

The aim of the study was to measure the effect of the cannabinoid dronabinol (THC) on nocturnal motor activity.

RESULTS:

Compared to baseline, dronabinol led to a reduction in nocturnal motor activity. These findings were corroborated by improvements in Neuropsychiatric Inventory total score as well as in subscores for agitation, aberrant motor, and nighttime behaviors . No side effects were observed.

CONCLUSIONS:

The study suggests that dronabinol (THC) was able to reduce nocturnal motor activity and agitation in severely demented patients. Thus, it appears that dronabinol (THC) may be a safe new treatment option for behavioral and circadian disturbances in dementia.”

http://www.ncbi.nlm.nih.gov/pubmed/16521031

https://link.springer.com/article/10.1007%2Fs00213-006-0343-1

Facebook Twitter Pinterest Stumbleupon Tumblr Posterous

One thought on “Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia.

  1. Thank you a lot for giving everyone such a terrific chance to read from here. It is often very brilliant plus stuffed with fun for me and my office friends to visit your website at a minimum 3 times every week to see the newest things you have got. And indeed, I am just actually motivated with the breathtaking methods you give. Selected two points in this posting are truly the simplest we’ve ever had.

Leave a Reply

Your email address will not be published. Required fields are marked *